世界の診断バイオマーカー市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Diagnostic Biomarker Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z1843 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、診断バイオマーカーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（S100、MART-1、Gp100、HMB45、AFP、BCR-ABL、その他）、用途別市場規模（病院、がん研究機関、診断研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・診断バイオマーカーの市場動向 ・企業の競争状況、市場シェア ・診断バイオマーカーの種類別市場規模（S100、MART-1、Gp100、HMB45、AFP、BCR-ABL、その他） ・診断バイオマーカーの用途別市場規模（病院、がん研究機関、診断研究所） ・診断バイオマーカーの北米市場規模2016-2027（アメリカ、カナダ） ・診断バイオマーカーのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・診断バイオマーカーのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・診断バイオマーカーの中南米市場規模2016-2027（メキシコ、ブラジル） ・診断バイオマーカーの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Biocrates Life Sciences、Augurex Life Sciences、Biomedical、Target Discovery、Banyan Biomarkers、Astute Medical、Axela） ・結論

Biomarkers have its property and the biological functions or molecules that are detected in various vitals of the body such as blood and other fluids. Further, they are then measured in those parts. They may indicate either normal or diseased processes in the body. Biomarkers are used in various purposes such as disease diagnosis, prognosis, prediction and assessment of treatment response. The diagnostic biomarkers have early inferences for detection of Patent Ductus Arteriosus (PDA). Predictive markers provides personalize treatment regimens and prognostic markers predict patient survival and recurrence patterns. Biomarkers are used for clinical diagnostics for detecting multiple diseases, for instance, creatinine for diagnosing renal insufficiency, troponin level for diagnosing myocardial infarction and amylase for pancreatitis.
Revenue growth in the diagnostic biomarker is expected to gain traction in the near future as they are dependent on the prevalence of diseases such as cancer and other cardiac problems. Significant growth the sector of molecular biology and advancements in various laboratory techniques is expected to support the diagnostic biomarker market over the forecast period. The advancement in the technology and rise in adoption rate of the biomarkers in diagnosis has expanded the feasibility of the use of biomarkers in diagnosis of various disorders such as genetic, cardiac, cancer and other immunological diseases. Also, for clinical investigators the biomarkers can be a dynamic and powerful tool to analyze the spectrum of neurological disease.

Market Analysis and Insights: Global Diagnostic Biomarker Market
The global Diagnostic Biomarker market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Diagnostic Biomarker market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Diagnostic Biomarker market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Diagnostic Biomarker market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Diagnostic Biomarker market.

Global Diagnostic Biomarker Scope and Market Size
Diagnostic Biomarker market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Diagnostic Biomarker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
S100
MART-1
Gp100
HMB45
AFP
BCR-ABL
Others

Segment by Application
Hospitals
Cancer Research Institutes
Diagnostic Labs

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biocrates Life Sciences
Augurex Life Sciences
Biomedical
Target Discovery
Banyan Biomarkers
Astute Medical
Axela

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diagnostic Biomarker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 S100
1.2.3 MART-1
1.2.4 Gp100
1.2.5 HMB45
1.2.6 AFP
1.2.7 BCR-ABL
1.2.8 Others
1.3 Market by Application
1.3.1 Global Diagnostic Biomarker Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Cancer Research Institutes
1.3.4 Diagnostic Labs
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Diagnostic Biomarker Market Perspective (2016-2027)
2.2 Diagnostic Biomarker Growth Trends by Regions
2.2.1 Diagnostic Biomarker Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Diagnostic Biomarker Historic Market Share by Regions (2016-2021)
2.2.3 Diagnostic Biomarker Forecasted Market Size by Regions (2022-2027)
2.3 Diagnostic Biomarker Industry Dynamic
2.3.1 Diagnostic Biomarker Market Trends
2.3.2 Diagnostic Biomarker Market Drivers
2.3.3 Diagnostic Biomarker Market Challenges
2.3.4 Diagnostic Biomarker Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Diagnostic Biomarker Players by Revenue
3.1.1 Global Top Diagnostic Biomarker Players by Revenue (2016-2021)
3.1.2 Global Diagnostic Biomarker Revenue Market Share by Players (2016-2021)
3.2 Global Diagnostic Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Diagnostic Biomarker Revenue
3.4 Global Diagnostic Biomarker Market Concentration Ratio
3.4.1 Global Diagnostic Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diagnostic Biomarker Revenue in 2020
3.5 Diagnostic Biomarker Key Players Head office and Area Served
3.6 Key Players Diagnostic Biomarker Product Solution and Service
3.7 Date of Enter into Diagnostic Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Diagnostic Biomarker Breakdown Data by Type
4.1 Global Diagnostic Biomarker Historic Market Size by Type (2016-2021)
4.2 Global Diagnostic Biomarker Forecasted Market Size by Type (2022-2027)

5 Diagnostic Biomarker Breakdown Data by Application
5.1 Global Diagnostic Biomarker Historic Market Size by Application (2016-2021)
5.2 Global Diagnostic Biomarker Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Diagnostic Biomarker Market Size (2016-2027)
6.2 North America Diagnostic Biomarker Market Size by Type
6.2.1 North America Diagnostic Biomarker Market Size by Type (2016-2021)
6.2.2 North America Diagnostic Biomarker Market Size by Type (2022-2027)
6.2.3 North America Diagnostic Biomarker Market Size by Type (2016-2027)
6.3 North America Diagnostic Biomarker Market Size by Application
6.3.1 North America Diagnostic Biomarker Market Size by Application (2016-2021)
6.3.2 North America Diagnostic Biomarker Market Size by Application (2022-2027)
6.3.3 North America Diagnostic Biomarker Market Size by Application (2016-2027)
6.4 North America Diagnostic Biomarker Market Size by Country
6.4.1 North America Diagnostic Biomarker Market Size by Country (2016-2021)
6.4.2 North America Diagnostic Biomarker Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Diagnostic Biomarker Market Size (2016-2027)
7.2 Europe Diagnostic Biomarker Market Size by Type
7.2.1 Europe Diagnostic Biomarker Market Size by Type (2016-2021)
7.2.2 Europe Diagnostic Biomarker Market Size by Type (2022-2027)
7.2.3 Europe Diagnostic Biomarker Market Size by Type (2016-2027)
7.3 Europe Diagnostic Biomarker Market Size by Application
7.3.1 Europe Diagnostic Biomarker Market Size by Application (2016-2021)
7.3.2 Europe Diagnostic Biomarker Market Size by Application (2022-2027)
7.3.3 Europe Diagnostic Biomarker Market Size by Application (2016-2027)
7.4 Europe Diagnostic Biomarker Market Size by Country
7.4.1 Europe Diagnostic Biomarker Market Size by Country (2016-2021)
7.4.2 Europe Diagnostic Biomarker Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Diagnostic Biomarker Market Size (2016-2027)
8.2 Asia-Pacific Diagnostic Biomarker Market Size by Type
8.2.1 Asia-Pacific Diagnostic Biomarker Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Diagnostic Biomarker Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Diagnostic Biomarker Market Size by Type (2016-2027)
8.3 Asia-Pacific Diagnostic Biomarker Market Size by Application
8.3.1 Asia-Pacific Diagnostic Biomarker Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Diagnostic Biomarker Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Diagnostic Biomarker Market Size by Application (2016-2027)
8.4 Asia-Pacific Diagnostic Biomarker Market Size by Region
8.4.1 Asia-Pacific Diagnostic Biomarker Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Diagnostic Biomarker Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Diagnostic Biomarker Market Size (2016-2027)
9.2 Latin America Diagnostic Biomarker Market Size by Type
9.2.1 Latin America Diagnostic Biomarker Market Size by Type (2016-2021)
9.2.2 Latin America Diagnostic Biomarker Market Size by Type (2022-2027)
9.2.3 Latin America Diagnostic Biomarker Market Size by Type (2016-2027)
9.3 Latin America Diagnostic Biomarker Market Size by Application
9.3.1 Latin America Diagnostic Biomarker Market Size by Application (2016-2021)
9.3.2 Latin America Diagnostic Biomarker Market Size by Application (2022-2027)
9.3.3 Latin America Diagnostic Biomarker Market Size by Application (2016-2027)
9.4 Latin America Diagnostic Biomarker Market Size by Country
9.4.1 Latin America Diagnostic Biomarker Market Size by Country (2016-2021)
9.4.2 Latin America Diagnostic Biomarker Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Diagnostic Biomarker Market Size (2016-2027)
10.2 Middle East & Africa Diagnostic Biomarker Market Size by Type
10.2.1 Middle East & Africa Diagnostic Biomarker Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Diagnostic Biomarker Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Diagnostic Biomarker Market Size by Type (2016-2027)
10.3 Middle East & Africa Diagnostic Biomarker Market Size by Application
10.3.1 Middle East & Africa Diagnostic Biomarker Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Diagnostic Biomarker Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Diagnostic Biomarker Market Size by Application (2016-2027)
10.4 Middle East & Africa Diagnostic Biomarker Market Size by Country
10.4.1 Middle East & Africa Diagnostic Biomarker Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Diagnostic Biomarker Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biocrates Life Sciences
11.1.1 Biocrates Life Sciences Company Details
11.1.2 Biocrates Life Sciences Business Overview
11.1.3 Biocrates Life Sciences Diagnostic Biomarker Introduction
11.1.4 Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2016-2021)
11.1.5 Biocrates Life Sciences Recent Development
11.2 Augurex Life Sciences
11.2.1 Augurex Life Sciences Company Details
11.2.2 Augurex Life Sciences Business Overview
11.2.3 Augurex Life Sciences Diagnostic Biomarker Introduction
11.2.4 Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2016-2021)
11.2.5 Augurex Life Sciences Recent Development
11.3 Biomedical
11.3.1 Biomedical Company Details
11.3.2 Biomedical Business Overview
11.3.3 Biomedical Diagnostic Biomarker Introduction
11.3.4 Biomedical Revenue in Diagnostic Biomarker Business (2016-2021)
11.3.5 Biomedical Recent Development
11.4 Target Discovery
11.4.1 Target Discovery Company Details
11.4.2 Target Discovery Business Overview
11.4.3 Target Discovery Diagnostic Biomarker Introduction
11.4.4 Target Discovery Revenue in Diagnostic Biomarker Business (2016-2021)
11.4.5 Target Discovery Recent Development
11.5 Banyan Biomarkers
11.5.1 Banyan Biomarkers Company Details
11.5.2 Banyan Biomarkers Business Overview
11.5.3 Banyan Biomarkers Diagnostic Biomarker Introduction
11.5.4 Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2016-2021)
11.5.5 Banyan Biomarkers Recent Development
11.6 Astute Medical
11.6.1 Astute Medical Company Details
11.6.2 Astute Medical Business Overview
11.6.3 Astute Medical Diagnostic Biomarker Introduction
11.6.4 Astute Medical Revenue in Diagnostic Biomarker Business (2016-2021)
11.6.5 Astute Medical Recent Development
11.7 Axela
11.7.1 Axela Company Details
11.7.2 Axela Business Overview
11.7.3 Axela Diagnostic Biomarker Introduction
11.7.4 Axela Revenue in Diagnostic Biomarker Business (2016-2021)
11.7.5 Axela Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Diagnostic Biomarker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of S100
Table 3. Key Players of MART-1
Table 4. Key Players of Gp100
Table 5. Key Players of HMB45
Table 6. Key Players of AFP
Table 7. Key Players of BCR-ABL
Table 8. Key Players of Others
Table 9. Global Diagnostic Biomarker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Diagnostic Biomarker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Diagnostic Biomarker Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Diagnostic Biomarker Market Share by Regions (2016-2021)
Table 13. Global Diagnostic Biomarker Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Diagnostic Biomarker Market Share by Regions (2022-2027)
Table 15. Diagnostic Biomarker Market Trends
Table 16. Diagnostic Biomarker Market Drivers
Table 17. Diagnostic Biomarker Market Challenges
Table 18. Diagnostic Biomarker Market Restraints
Table 19. Global Diagnostic Biomarker Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Diagnostic Biomarker Market Share by Players (2016-2021)
Table 21. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Biomarker as of 2020)
Table 22. Ranking of Global Top Diagnostic Biomarker Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Diagnostic Biomarker Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Diagnostic Biomarker Product Solution and Service
Table 26. Date of Enter into Diagnostic Biomarker Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Diagnostic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Diagnostic Biomarker Revenue Market Share by Type (2016-2021)
Table 30. Global Diagnostic Biomarker Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Diagnostic Biomarker Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Diagnostic Biomarker Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Diagnostic Biomarker Revenue Market Share by Application (2016-2021)
Table 34. Global Diagnostic Biomarker Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Diagnostic Biomarker Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Diagnostic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Diagnostic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Diagnostic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Diagnostic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Diagnostic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Diagnostic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Diagnostic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Diagnostic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Diagnostic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Diagnostic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Diagnostic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Diagnostic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Diagnostic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Diagnostic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Diagnostic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Diagnostic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Diagnostic Biomarker Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Diagnostic Biomarker Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Diagnostic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Diagnostic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Diagnostic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Diagnostic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Diagnostic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Diagnostic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Diagnostic Biomarker Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Diagnostic Biomarker Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Diagnostic Biomarker Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Diagnostic Biomarker Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Diagnostic Biomarker Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Diagnostic Biomarker Market Size by Country (2022-2027) & (US$ Million)
Table 66. Biocrates Life Sciences Company Details
Table 67. Biocrates Life Sciences Business Overview
Table 68. Biocrates Life Sciences Diagnostic Biomarker Product
Table 69. Biocrates Life Sciences Revenue in Diagnostic Biomarker Business (2016-2021) & (US$ Million)
Table 70. Biocrates Life Sciences Recent Development
Table 71. Augurex Life Sciences Company Details
Table 72. Augurex Life Sciences Business Overview
Table 73. Augurex Life Sciences Diagnostic Biomarker Product
Table 74. Augurex Life Sciences Revenue in Diagnostic Biomarker Business (2016-2021) & (US$ Million)
Table 75. Augurex Life Sciences Recent Development
Table 76. Biomedical Company Details
Table 77. Biomedical Business Overview
Table 78. Biomedical Diagnostic Biomarker Product
Table 79. Biomedical Revenue in Diagnostic Biomarker Business (2016-2021) & (US$ Million)
Table 80. Biomedical Recent Development
Table 81. Target Discovery Company Details
Table 82. Target Discovery Business Overview
Table 83. Target Discovery Diagnostic Biomarker Product
Table 84. Target Discovery Revenue in Diagnostic Biomarker Business (2016-2021) & (US$ Million)
Table 85. Target Discovery Recent Development
Table 86. Banyan Biomarkers Company Details
Table 87. Banyan Biomarkers Business Overview
Table 88. Banyan Biomarkers Diagnostic Biomarker Product
Table 89. Banyan Biomarkers Revenue in Diagnostic Biomarker Business (2016-2021) & (US$ Million)
Table 90. Banyan Biomarkers Recent Development
Table 91. Astute Medical Company Details
Table 92. Astute Medical Business Overview
Table 93. Astute Medical Diagnostic Biomarker Product
Table 94. Astute Medical Revenue in Diagnostic Biomarker Business (2016-2021) & (US$ Million)
Table 95. Astute Medical Recent Development
Table 96. Axela Company Details
Table 97. Axela Business Overview
Table 98. Axela Diagnostic Biomarker Product
Table 99. Axela Revenue in Diagnostic Biomarker Business (2016-2021) & (US$ Million)
Table 100. Axela Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diagnostic Biomarker Market Share by Type: 2020 VS 2027
Figure 2. S100 Features
Figure 3. MART-1 Features
Figure 4. Gp100 Features
Figure 5. HMB45 Features
Figure 6. AFP Features
Figure 7. BCR-ABL Features
Figure 8. Others Features
Figure 9. Global Diagnostic Biomarker Market Share by Application: 2020 VS 2027
Figure 10. Hospitals Case Studies
Figure 11. Cancer Research Institutes Case Studies
Figure 12. Diagnostic Labs Case Studies
Figure 13. Diagnostic Biomarker Report Years Considered
Figure 14. Global Diagnostic Biomarker Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Diagnostic Biomarker Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Diagnostic Biomarker Market Share by Regions: 2020 VS 2027
Figure 17. Global Diagnostic Biomarker Market Share by Regions (2022-2027)
Figure 18. Global Diagnostic Biomarker Market Share by Players in 2020
Figure 19. Global Top Diagnostic Biomarker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Diagnostic Biomarker as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Diagnostic Biomarker Revenue in 2020
Figure 21. Global Diagnostic Biomarker Revenue Market Share by Type (2016-2021)
Figure 22. Global Diagnostic Biomarker Revenue Market Share by Type (2022-2027)
Figure 23. North America Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Diagnostic Biomarker Market Share by Type (2016-2027)
Figure 25. North America Diagnostic Biomarker Market Share by Application (2016-2027)
Figure 26. North America Diagnostic Biomarker Market Share by Country (2016-2027)
Figure 27. United States Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Diagnostic Biomarker Market Share by Type (2016-2027)
Figure 31. Europe Diagnostic Biomarker Market Share by Application (2016-2027)
Figure 32. Europe Diagnostic Biomarker Market Share by Country (2016-2027)
Figure 33. Germany Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Diagnostic Biomarker Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Diagnostic Biomarker Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Diagnostic Biomarker Market Share by Region (2016-2027)
Figure 43. China Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Diagnostic Biomarker Market Share by Type (2016-2027)
Figure 51. Latin America Diagnostic Biomarker Market Share by Application (2016-2027)
Figure 52. Latin America Diagnostic Biomarker Market Share by Country (2016-2027)
Figure 53. Mexico Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Diagnostic Biomarker Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Diagnostic Biomarker Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Diagnostic Biomarker Market Share by Country (2016-2027)
Figure 59. Turkey Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Diagnostic Biomarker Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Biocrates Life Sciences Revenue Growth Rate in Diagnostic Biomarker Business (2016-2021)
Figure 63. Augurex Life Sciences Revenue Growth Rate in Diagnostic Biomarker Business (2016-2021)
Figure 64. Biomedical Revenue Growth Rate in Diagnostic Biomarker Business (2016-2021)
Figure 65. Target Discovery Revenue Growth Rate in Diagnostic Biomarker Business (2016-2021)
Figure 66. Banyan Biomarkers Revenue Growth Rate in Diagnostic Biomarker Business (2016-2021)
Figure 67. Astute Medical Revenue Growth Rate in Diagnostic Biomarker Business (2016-2021)
Figure 68. Axela Revenue Growth Rate in Diagnostic Biomarker Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

---